all participants experience the rapid progress and the ability to co-steer iterative development, and once this agile team experience is established the project can only succeed.
About the Authors
Jochen Scheel , Director of Software Development, and Stefan Meier , Associate Director, work as part of XDx's Information Sciences Department.
About XDx
Founded in 2000, XDx Inc., a molecular diagnostics company from Brisbane, California, is on the fast track to a new era in personalized medicine. XDx focuses on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. The company has developed a proprietary new method of utilizing gene expression that provides additional options to current patient management by physicians specializing in these disease areas. This work is the basis for AlloMap® Molecular Expression Testing.
One of the first companies to develop and bring to market products and therapies derived from the fundamental Human Genome Project, XDx has devised a new method for non-invasively monitoring the immune system by measuring gene expression in a patient's peripheral blood. This technology has huge potential to decrease healthcare costs and improve the quality of life for patients suffering from a variety of immune-mediated diseases.
Pages
About the author
The opinions and positions expressed within these guest posts are those of the author alone and do not represent those of the TechWell Community Sites. Guest authors represent that they have the right to distribute this content and that such content is not violating the legal rights of others. If you would like to contribute content to a TechWell Community Site, email editors@techwell.com.
